175 related articles for article (PubMed ID: 15572379)
1. A novel role for vascular endothelial growth factor as an autocrine survival factor for embryonic stem cells during hypoxia.
Brusselmans K; Bono F; Collen D; Herbert JM; Carmeliet P; Dewerchin M
J Biol Chem; 2005 Feb; 280(5):3493-9. PubMed ID: 15572379
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia activates matrix metalloproteinase expression and the VEGF system in monkey choroid-retinal endothelial cells: Involvement of cytosolic phospholipase A2 activity.
Ottino P; Finley J; Rojo E; Ottlecz A; Lambrou GN; Bazan HE; Bazan NG
Mol Vis; 2004 May; 10():341-50. PubMed ID: 15162095
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha--> hypoxia response element--> VEGF cascade differentially regulates vascular response and growth rate in tumors.
Tsuzuki Y; Fukumura D; Oosthuyse B; Koike C; Carmeliet P; Jain RK
Cancer Res; 2000 Nov; 60(22):6248-52. PubMed ID: 11103778
[TBL] [Abstract][Full Text] [Related]
4. Expression and regulation of vascular endothelial growth factor ligands and receptors during menstruation and post-menstrual repair of human endometrium.
Punyadeera C; Thijssen VL; Tchaikovski S; Kamps R; Delvoux B; Dunselman GA; de Goeij AF; Griffioen AW; Groothuis PG
Mol Hum Reprod; 2006 Jun; 12(6):367-75. PubMed ID: 16648151
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
Simiantonaki N; Jayasinghe C; Michel-Schmidt R; Peters K; Hermanns MI; Kirkpatrick CJ
Int J Oncol; 2008 Mar; 32(3):585-92. PubMed ID: 18292935
[TBL] [Abstract][Full Text] [Related]
6. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
7. Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity.
Teran M; Nugent MA
J Biol Chem; 2015 Jun; 290(26):16451-62. PubMed ID: 25979342
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor regulates stanniocalcin-1 expression via neuropilin-1-dependent regulation of KDR and synergism with fibroblast growth factor-2.
Holmes DI; Zachary IC
Cell Signal; 2008 Mar; 20(3):569-79. PubMed ID: 18164591
[TBL] [Abstract][Full Text] [Related]
9. Expression of vascular endothelial growth factor (VEGF) mRNA, VEGF receptor 2 (Flk-1) mRNA, and of VEGF co-receptor neuropilin (Nrp)-1 mRNA in brain tissue of aging Tg2576 mice by in situ hybridization.
Muche A; Bigl M; Arendt T; Schliebs R
Int J Dev Neurosci; 2015 Jun; 43():25-34. PubMed ID: 25797338
[TBL] [Abstract][Full Text] [Related]
10. Neuropilin-1 modulates vascular endothelial growth factor-induced poly(ADP-ribose)-polymerase leading to reduced cerebrovascular apoptosis.
Mey L; Hörmann M; Schleicher N; Reuter P; Dönges S; Kinscherf R; Gassmann M; Gerriets T; Al-Fakhri N
Neurobiol Dis; 2013 Nov; 59():111-25. PubMed ID: 23816753
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia affects mesoderm and enhances hemangioblast specification during early development.
Ramírez-Bergeron DL; Runge A; Dahl KD; Fehling HJ; Keller G; Simon MC
Development; 2004 Sep; 131(18):4623-34. PubMed ID: 15342485
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory activity of ranibizumab, sorafenib, and pazopanib on light-induced overexpression of platelet-derived growth factor and vascular endothelial growth factor A and the vascular endothelial growth factor A receptors 1 and 2 and neuropilin 1 and 2.
Kernt M; Thiele S; Neubauer AS; Koenig S; Hirneiss C; Haritoglou C; Ulbig MW; Kampik A
Retina; 2012 Sep; 32(8):1652-63. PubMed ID: 22466477
[TBL] [Abstract][Full Text] [Related]
13. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of neuropilin-1 by basic fibroblast growth factor enhances vascular smooth muscle cell migration in response to VEGF.
Liu W; Parikh AA; Stoeltzing O; Fan F; McCarty MF; Wey J; Hicklin DJ; Ellis LM
Cytokine; 2005 Dec; 32(5):206-12. PubMed ID: 16289960
[TBL] [Abstract][Full Text] [Related]
15. A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma.
Das B; Yeger H; Tsuchida R; Torkin R; Gee MF; Thorner PS; Shibuya M; Malkin D; Baruchel S
Cancer Res; 2005 Aug; 65(16):7267-75. PubMed ID: 16103078
[TBL] [Abstract][Full Text] [Related]
16. Prenatal hypoxia downregulates the expression of pulmonary vascular endothelial growth factor and its receptors in fetal mice.
Tsao PN; Wei SC
Neonatology; 2013; 103(4):300-7. PubMed ID: 23548588
[TBL] [Abstract][Full Text] [Related]
17. Modeling of diseases of retinal ischemia in vitro: possible participation of autocrine vascular endothelial growth factor signaling.
Yan Y; He T; Shen Y; Chen X; Diao B; Li Z; Zhou F; Xing YQ
Ophthalmic Res; 2013; 49(2):90-9. PubMed ID: 23257772
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible transcription factor-1alpha triggers an autocrine survival pathway during embryonic cardiac outflow tract remodeling.
Liu H; Fisher SA
Circ Res; 2008 Jun; 102(11):1331-9. PubMed ID: 18467628
[TBL] [Abstract][Full Text] [Related]
19. Combined inhibition of vascular endothelial growth factor receptor signaling with temozolomide enhances cytotoxicity against human glioblastoma cells via downregulation of Neuropilin-1.
Lee J; Kim E; Ryu SW; Choi C; Choi K
J Neurooncol; 2016 May; 128(1):29-34. PubMed ID: 26951556
[TBL] [Abstract][Full Text] [Related]
20. Fasudil-induced hypoxia-inducible factor-1alpha degradation disrupts a hypoxia-driven vascular endothelial growth factor autocrine mechanism in endothelial cells.
Takata K; Morishige K; Takahashi T; Hashimoto K; Tsutsumi S; Yin L; Ohta T; Kawagoe J; Takahashi K; Kurachi H
Mol Cancer Ther; 2008 Jun; 7(6):1551-61. PubMed ID: 18566226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
